Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL692036 | 0.91 | NPSR1 (0.56) | NPSR1PRKCAPKML3MBTL1ALDH1A1 | |
| SCHEMBL12104097 | 0.83 | NPSR1 (0.39) | NPSR1PRKCAL3MBTL1ALDH1A1LMNA | |
| SCHEMBL13124791 | 0.80 | NPSR1 (0.44) | NPSR1PRKCAPKML3MBTL1ALDH1A1 | |
| SCHEMBL6863134 | 0.78 | NPSR1 (0.57) | NPSR1PRKCAL3MBTL1ALDH1A1MEN1 | |
| SCHEMBL12104073 | 0.75 | NPSR1 (0.45) | NPSR1PKML3MBTL1ALDH1A1MEN1 | |
| SCHEMBL7800500 | 0.74 | NPSR1 (0.47) | NPSR1PRKCAPKML3MBTL1ALDH1A1 | |
| SCHEMBL13628679 | 0.73 | EPHX2 (0.34) | EPHX2 | |
| SCHEMBL13628689 | 0.72 | TSHR (0.39) | NPSR1ALDH1A1LMNAEPHX2TSHR | |
| SCHEMBL14461674 | 0.72 | NPSR1 (0.51) | NPSR1PRKCAL3MBTL1ALDH1A1LMNA | |
| SCHEMBL14461668 | 0.72 | PRKCA (0.55) | NPSR1PRKCAPKMALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612155-B2 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | C1S, C1R, MLX | NPSR1 848/4885PRKCA 2903/4885PKM 3715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.